How Much Did Tedor Pharma Raise?
Funding & Key Investors

Tedor Pharma has solidified its position within the pharmaceutical manufacturing landscape, securing a total capital infusion of $1.9M. This trajectory of financial backing, highlighted by a recent strategic investment of $949K, underscores the firm's commitment to expanding its high-capacity production capabilities. By leveraging these debt-based financing instruments, the organization continues to fortify its balance sheet while maintaining operational agility in a highly regulated sector.

What is Tedor Pharma?

Tedor Pharma
ManufacturingPharmaceuticalsBusiness Services

Tedor Pharma operates as a premier contract development and manufacturing organization (CDMO) based in the United States, specializing in the production of solid dose pharmaceuticals and controlled substances. With a legacy spanning over two decades, the company provides an integrated suite of services that encompasses formulation development, analytical testing, and clinical trial supply management. Their FDA-registered and DEA-licensed infrastructure serves as a critical node in the supply chain for small molecule drug developers, offering end-to-end outsourcing solutions that prioritize regulatory compliance and manufacturing precision. By maintaining state-of-the-art facilities, Tedor Pharma effectively bridges the gap between early-stage drug development and commercial-scale production, ensuring that complex pharmaceutical products meet rigorous quality standards before reaching the market.

How much funding has Tedor Pharma raised?

Tedor Pharma has raised a total of $1.9M across 2 funding rounds:

2020

Debt

$1M

2021

Debt

$949K

Debt (2020): $1M with participation from PPP

Debt (2021): $949K led by PPP

Key Investors in Tedor Pharma

PPP

Public-Private Partnership

What's next for Tedor Pharma?

With the recent influx of capital, Tedor Pharma is well-positioned to accelerate its strategic growth initiatives, focusing on the optimization of its manufacturing processes and the expansion of its service portfolio. The company is expected to leverage this financial runway to enhance its technical infrastructure, potentially increasing its capacity for handling complex controlled substances and specialized solid dose formulations. As the pharmaceutical industry continues to demand more flexible and reliable outsourcing partners, Tedor Pharma's focus on operational excellence and regulatory adherence will likely serve as a primary driver for long-term market share acquisition. Future developments will likely center on scaling production throughput and deepening partnerships with emerging biotech firms requiring robust, compliant manufacturing support.

See full Tedor Pharma company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingToys & GamesRetail
Industrial Machinery & EquipmentManufacturing
Industrial Machinery & EquipmentManufacturingOther Rental Stores (Furniture, A/V, Construction & Industrial Equipment)Retail
Food & BeverageManufacturingRetailConvenience Stores, Gas Stations & Liquor Stores

Frequently Asked Questions Regarding Tedor Pharma Financial Insights

What are the most recent funding rounds that Tedor Pharma has completed, and what were the funding rounds?
Tedor Pharma has recently completed 2 funding rounds: Debt on Feb 10, 2021, Debt on Apr 28, 2020.
What is the total amount of funding Tedor Pharma has raised to date?
Tedor Pharma has raised a total of $1.9M in funding to date.
How many funding rounds has Tedor Pharma completed?
Tedor Pharma has completed 2 funding rounds.
How much funding did Tedor Pharma raise in its most recent funding round?
Tedor Pharma raised $949K in its most recent funding round.
Who are the lead investors in Tedor Pharma's latest funding round?
The lead investor in Tedor Pharma's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Tedor Pharma's history?
The largest funding round in Tedor Pharma's history was $1M.
See more information about Tedor Pharma